Cargando…
NK Cell Plasticity in Cancer
Natural killer (NK) cells are critical immune components in controlling tumor growth and dissemination. Given their innate capacity to eliminate tumor cells without prior sensitization, NK-based therapies for cancer are actively pursued pre-clinically and clinically. However, recent data suggest tha...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780970/ https://www.ncbi.nlm.nih.gov/pubmed/31546818 http://dx.doi.org/10.3390/jcm8091492 |
_version_ | 1783457267735068672 |
---|---|
author | Liu, Sizhe Dhar, Payal Wu, Jennifer D. |
author_facet | Liu, Sizhe Dhar, Payal Wu, Jennifer D. |
author_sort | Liu, Sizhe |
collection | PubMed |
description | Natural killer (NK) cells are critical immune components in controlling tumor growth and dissemination. Given their innate capacity to eliminate tumor cells without prior sensitization, NK-based therapies for cancer are actively pursued pre-clinically and clinically. However, recent data suggest that tumors could induce functional alterations in NK cells, polarizing them to tumor-promoting phenotypes. The potential functional plasticity of NK cells in the context of tumors could lead to undesirable outcomes of NK-cell based therapies. In this review, we will summarize to-date evidence of tumor-associated NK cell plasticity and provide our insights for future investigations and therapy development. |
format | Online Article Text |
id | pubmed-6780970 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-67809702019-10-30 NK Cell Plasticity in Cancer Liu, Sizhe Dhar, Payal Wu, Jennifer D. J Clin Med Review Natural killer (NK) cells are critical immune components in controlling tumor growth and dissemination. Given their innate capacity to eliminate tumor cells without prior sensitization, NK-based therapies for cancer are actively pursued pre-clinically and clinically. However, recent data suggest that tumors could induce functional alterations in NK cells, polarizing them to tumor-promoting phenotypes. The potential functional plasticity of NK cells in the context of tumors could lead to undesirable outcomes of NK-cell based therapies. In this review, we will summarize to-date evidence of tumor-associated NK cell plasticity and provide our insights for future investigations and therapy development. MDPI 2019-09-19 /pmc/articles/PMC6780970/ /pubmed/31546818 http://dx.doi.org/10.3390/jcm8091492 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Liu, Sizhe Dhar, Payal Wu, Jennifer D. NK Cell Plasticity in Cancer |
title | NK Cell Plasticity in Cancer |
title_full | NK Cell Plasticity in Cancer |
title_fullStr | NK Cell Plasticity in Cancer |
title_full_unstemmed | NK Cell Plasticity in Cancer |
title_short | NK Cell Plasticity in Cancer |
title_sort | nk cell plasticity in cancer |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780970/ https://www.ncbi.nlm.nih.gov/pubmed/31546818 http://dx.doi.org/10.3390/jcm8091492 |
work_keys_str_mv | AT liusizhe nkcellplasticityincancer AT dharpayal nkcellplasticityincancer AT wujenniferd nkcellplasticityincancer |